Covid-19 mortality in children and adolescents in Mexico.

OBJECTIVE: To estimate Covid-19 and pre-pandemic low respiratory infection (LRI) mortality in children and adolescents in Mexico. MATERIALS AND METHODS: We estimated the percentage of total mortality attributable to Covid-19 (95% confidence intervals; 95%CI) and made the corresponding estimates for pre-pandemic LRI mortality. RESULTS: In 2019, LRIs represented 8.6% (95%CI 8.3, 8.9) of deaths in children aged 0-9 years, and 2.0% (95%CI 1.8, 2.3) in those aged 10-19 years. In 2020, the corresponding estimates for Covid-19 were 4.4% (95%CI 4.1, 4.6) and 3.7% (95%CI 3.4, 4.1). CONCLUSIONS: Relative to LRI, Covid-19 may be exerting a considerable mortality burden, particularly in older children and adolescents.

Covid-19 mortality in children and adolescents in Mexico / Mortalidad por Covid-19 en niños y adolescentes en México

Abstract: Objective: To estimate Covid-19 and pre-pandemic low respiratory infection (LRI) mortality in children and adolescents in Mexico. Materials and methods: We estimated the percentage of total mortality attributable to Covid-19 (95% confidence intervals; 95%CI) and made the corresponding estimates for pre-pandemic LRI mortality. Results: In 2019, LRIs represented 8.6% (95%CI 8.3, 8.9) of deaths in children aged 0-9 years, and 2.0% (95%CI 1.8, 2.3) in those aged 10-19 years. In 2020, the corresponding estimates for Covid-19 were 4.4% (95%CI 4.1, 4.6) and 3.7% (95%CI 3.4, 4.1). Conclusions: Relative to LRI, Covid-19 may be exerting a considerable mortality burden, particularly in older children and adolescents.

Resumen: Objetivo: Estimar la mortalidad por Covid-19 e infección respiratoria baja (IRB) pre-pandémica en niños y adolescentes en México. Material y métodos: Se estimó el porcentaje de mortalidad atribuible a Covid-19 (intervalos de confianza 95%; IC95%) y se realizaron las estimaciones correspondientes para IRB pre-pandémica. Resultados: En 2019, las IRB representaron 8.6% (IC95% 8.3, 8.9) de las muertes en niños de 0-9 años y 2.0% (IC95% 1.8, 2.3) en aquéllos entre 10-19 años. Los valores correspondientes en 2020 para Covid-19 fueron 4.4% (IC95% 4.1, 4.6) y 3.7% (IC95% 3.4, 4.1). Conclusiones: En comparación con IRB, Covid-19 puede estar ejerciendo una carga de mortalidad considerable, particularmente en niños mayores y adolescentes.

Seroprevalencia de SARS-CoV-2 en niños y adolescentes mexicanos en edad escolar / Seroprevalence of SARS-CoV-2 in Mexican children and adolescents in primary and secondary education age

Resumen: Objetivo: Estimar la seroprevalencia de SARS-CoV-2 en población de edad escolar en México. Material y métodos: Se categorizaron a niños y adolescentes que participaron en la Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19 (Ensanut 2020 Covid-19) por edad escolar y nivel educativo. En participantes seropositivos, se identificó la proporción de infecciones asintomáticas. Se estimaron razones de prevalencia usando un modelo de regresión log-binomial. Resultados: La seroprevalencia en educación básica y media fue de 18.7% (IC95%: 14.9, 22.5) y 26.7% (IC95%: 22.1, 31.3), respectivamente. La infección asintomática fue más frecuente en educación básica (88.5% [IC95%: 80.5, 93.5]). Conclusiones: En población de educación básica la infección por SARS-CoV-2 es baja y usualmente asintomática.

Abstract: Objective: To estimate the seroprevalence of SARS-CoV-2 in school aged children in Mexico. Materials and methods: We categorized children and adolescents who participated in the 2020 National Health and Nutrition Survey on Covid-19 according to school age and educational level. In seropositive participants, we identified the proportion of asymptomatic infections. We estimated prevalence ratios using a log-binomial regression model. Results: Seroprevalence of SARS-CoV-2 for primary and secondary education were 18.7% (95%IC: 14.9, 22.5) and 26.7% (95%IC: 22.1, 31.3), respectively. Asymptomatic infection was more frequent among primary school children (88.5% [95%IC: 80.5, 93.5]). Conclusions: In primary schoolchildren seroprevalence for SARS-CoV-2 was low and infections were usually asymptomatic.

Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.

COVID-19 affects the paediatric population less frequently than adults. A retrospective study was performed in a tertiary paediatric hospital in Mexico City in children <18 years of age who were hospitalized with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2. Included in the study were 86 patients with a median age of 10 years old (IQR 2.6-14.3 years), who were classified in three groups: previously healthy, with chronic disease and immunosuppressed patients. The principal signs and symptoms were fever (81%), cough (51%) and headache (35%). A total of 20 patients (23%) required management in the paediatric intensive care unit (PICU) and 17% needed mechanical ventilation for an average of 12.7 days (IQR 2-29 days). There was no statistically significant difference between the three clinical classification groups in those patients admitted to the PICU, most of which were previously healthy patients. The mortality rate was 5% (four patients). Given that the paediatric population is susceptible to infection, potential transmitters and to clinical presentations with variable degrees of severity, it is important to continue reinforcing social distancing measures.

Seroprevalencia de SARS-CoV-2 en niños y adolescentes mexicanos en edad escolar.

Objetivo. Estimar la seroprevalencia de SARS-CoV-2 en población de edad escolar en México. Material y métodos. Se categorizaron a niños y adolescentes que participaron en la Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19 (Ensanut 2020 Covid-19) por edad escolar y nivel educativo. En participantes seropositivos, se identificó la proporción de infecciones asintomáticas. Se estimaron razones de prevalencia usando un modelo de regresión log-binomial. Resultados. La seroprevalencia en educación básica y media fue de 18.7% (IC95%: 14.9, 22.5) y 26.7% (IC95%: 22.1, 31.3), respectivamente. La infección asintomática fue más frecuente en educación básica (88.5% [IC95%: 80.5, 93.5]). Conclusiones. En población de educación básica la infección por SARS-CoV-2 es baja y usualmente asintomática.

Case Report: Chest Wall Tuberculosis without Pulmonary Involvement in Three Pediatric Immunocompetent Patients.

Primary rib cage tuberculosis (TB) is an infrequent form of presentation and represents 1% of all cases of osteoarticular TB. We report three cases of children who were previously healthy and who began with swelling of the anterior surface of the rib as initial manifestation of TB. The most important clinical presentations in this series were swelling and pain, with lytic lesions and a soft tissue mass in image studies simulating oncologic pathologies. Because none of the cases had positive epidemiological contact, TB was initially not considered, so the delay in diagnosis from the onset of symptoms was 4, 1, and 2 months, respectively. The diagnosis was made through histomorphological analyses. Treatment was administered during 12, 10, and 9 months. Posttreatment studies did not show any evidence of extrapulmonary TB and until date, the patients remained without relapse or active disease. The findings in our cases illustrate that the diagnosis of chest wall TB should be suspected in all patients from endemic areas who present rib injury.

First clinical isolate of Escherichia coli harboring mcr-1 gene in Mexico.

Our aim in this report was to describe the characteristics of the first clinical isolate of Escherichia coli (EC-PAG-733) harboring the mcr-1 gene found in Mexico. This isolate was obtained from a fecal sample from a young child with an oncological condition. We obtained the whole-genome sequence using next-generation sequencing and analyzed the sequence by bioinformatics tools. EC-PAG-733 was resistant to third- and fourth-generation cephalosporins and was susceptible to all carbapenems and amikacin; it was also resistant to ciprofloxacin, levofloxacin, gentamicin and colistin at a minimum inhibitory concentration (MIC) of 4 µg/mL. This isolate was classified as O11:H25-ST457. EC-PAG-733 harbored an ESBL type CTX-M-55 as well as several virulence factors that have been associated with Enteroaggregative Escherichia coli (EAEC). The mcr-1 gene was located within an IncI2 plasmid. The results of this whole genome shotgun project were deposited in DDBJ/ENA/GenBank under the accession number QKXE00000000.

Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital.

BACKGROUND: Carbapenemases-producing Enterobacteriaceae (CPE) are a worldwide public health emergency. In Mexico, reports of CPE are limited, particularly in the pediatric population. Here, we describe the clinical, epidemiological, and molecular characteristics of seven consecutive cases in a third-level pediatric hospital in Mexico City over a four-month period during 2016. RESULTS: The Enterobacteriaceae identified were three Escherichia coli strains (producing OXA-232, NDM-1 and KPC-2), two Klebsiella pneumoniae strains (producing KPC-2 and NDM-1), one Klebsiella oxytoca strain producing OXA-48 and one Enterobacter cloacae strain producing NDM-1. The majority of patients had underlying disesases, three were immunocompromised, and three had infections involved the skin and soft tissues. Half patients died as a result of CPE infection. CONCLUSIONS: This study represents the first report of E. coli ST131-O25b clone producing NDM-1 in Latin America. In addition, this study is the first finding of K. oxytoca producing OXA-48 and E. coli producing OXA-232 in Mexican pediatric patients.